Virtu Financial’s iSpecimen ISPC Stock Holding History

Virtu Financial’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,581	Closed	-$82K	–	1934
2025 Q3	$82K	Buy	+1,581	New	+$74.2K	﹤0.01%	1071
2024 Q3	–	Sell	-53	Closed	-$13K	–	1618
2024 Q2	$13K	Buy	+53	New	+$12.7K	﹤0.01%	1096
2022 Q4	–	Sell	-13	Closed	-$18K	–	1877
2022 Q3	$18K	Buy	+13	New	+$23.3K	﹤0.01%	1420

Other funds holding ISPC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Virtu Financial's ISPC Position: Q4 2025 in Review

Virtu Financial sold out of iSpecimen (ISPC) in Q4 2025, closing a stake of 1,581 shares — an estimated $82K sold.

Virtu Financial first reported a position in ISPC in Q3 2022 and held it in 3 quarters. The position peaked at $82K in Q3 2025. 9 funds tracked by Wall St. Rank hold ISPC as of Q4 2025.

Virtu Financial reported no remaining iSpecimen position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 1,581 iSpecimen shares in Q4 2025, an estimated $82K.
Virtu Financial first reported a position in iSpecimen in Q3 2022 and held it in 3 quarters.
Virtu Financial's iSpecimen position peaked at $82K in Q3 2025.
9 funds tracked by Wall St. Rank held iSpecimen as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.